OurCrowd earns $200m from BioCatch exit...

The Jerusalem-based venture capital fund OurCrowd realized approximately $200 million from its stake in BioCatch following Visa's acquisition of the company. The transaction represents one of the fund's most profitable exits to date.

OurCrowd invests in Israeli startups and technology companies, with BioCatch operating in the field of behavioral biometrics and fraud prevention.